Protective effect of JBP485 on concanavalin A-induced hepatocyte toxicity in primary cultured rat hepatocytes

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 299-305

  Wu, Jingjing ^a   Wang, Changyuan ^a   Liu, Qi ^a   Yang, Tao ^a   Zhang, Qinghao ^a   Peng, Jinyong ^a   Gao, Ying ^a   Sun, Huijun ^a   Kaku, Taiichi ^b   Liu, Kexin ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Japan Bioproducts Industry Co Ltd   (Japan)

Author keywords

Apoptosis; Concanavalin A; ICAM 1; JBP485; Laennec; Primary cultured rat hepatocyte

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CELL DNA; CONCANAVALIN A; CYCLO 4 HYDROXYPROLYLSERINE; INTERCELLULAR ADHESION MOLECULE 1; JBP 485; LACTATE DEHYDROGENASE; LAENNEC; LIVER PROTECTIVE AGENT; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA DAMAGE; ENZYME RELEASE; FEMALE; LIVER CELL CULTURE; LIVER CELL DAMAGE; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL;

ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CASPASE 3; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COCULTURE TECHNIQUES; CONCANAVALIN A; CYTOPROTECTION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; L-LACTATE DEHYDROGENASE; LYMPHOCYTES; PEPTIDES, CYCLIC; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47549101579     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.066     Document Type: Article

References (30)

1. Berke G., McVey E., Hu V., and Clark W.R. T lymphocyte-mediated cytolysis: II. Role of target cell histocompatibility antigens in recognition and lysis. J. Immunol. 127 (1981) 782-787
2. Castell J.V., Gómez-Lechón M.J., Ponsoda X., and Bort R. The use of cultured hepatocytes to investigate the mechanisms of drug hepatotoxicity. Cell Biol. Toxicol. 13 (1997) 331-338
3. Chisari F.V. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 99 (1997) 1472-1477
4. Essani N.A., Fisher M.A., Fqarhood A., Manning A.M., Smith C.W., and Jaeschke H. Cytokine-induced up-regulation of hepatic intercellular-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 21 (1995) 1632-1639
5. Fautrel A., Chesne C., Guillouzo A., De Sousa G., Placidi M., Rahmani R., Braut F., Pichon J., Hoellinger H., Vintezou P., et al. A multicentre study of acute in vitro cytotoxicity in rat liver cells. Toxicol. In Vitro 5 (1991) 543-547
6. Gantner F., Leist M., Lohse A.W., Germann P.G., and Tiegs A. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21 (1995) 190-198
7. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., and Hengartner H. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265 (1994) 528-530
8. Kato Y., Liu K.X., Nakamura T., and Sugiyama Y. Heparin-hepatocytes growth factor (HGF) complex with low plasma clearance and retained hepatocyte proliferating activity. Hepatology 20 (1994) 417-422
9. Katzen H.M., Vicario P.P., Mumford R.A., and Green B.G. Evidence that the insulin-like activities of concanavalin A and insulin are mediated by a common insulin receptor linked effector system. Biochemistry 20 (1981) 5800-5809
10. Küsters S., Gantner F., Künstle G., and Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111 (1996) 462-471
11. Lapierre P., Béland K., and Alvarez F. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis. Trans. Res. 149 (2007) 107-113
12. Leist M., and Wendel A. A novel mechanism of murine hepatocyte death inducible by concanavalin A. J. Hepatol. 25 (1996) 948-959
13. Leist M., Gantner F., Bohlinger I., German P.G., Tiegs G., and Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF alpha requires transcription arrest. J. Immunol. 153 (1994) 1778-1787
14. Li Y., Liu F.-Y., Liu Z.H., Huang Y.F., Li L.-S., Zhang X., and Peng Y.-M. Effect of tacrolimus and cyclosporine A on suppression of albumin secretion induced by inflammatory cytokines in cultured human hepatocytes. Inflamm. Res. 55 (2006) 216-220
15. Liu K.X., Okazawa I., and Kaku T. Effect of Laennec on liver regeneration (in Japanese). Clin. Pharmacol. Ther. 5 (1995) 2187-2194
16. Liu K.X., Kato Y., Kaku T.I., Santa T., Imai K., Yagi A., Ishizu T., and Sugiyama Y. Hydroxyprolylserine derivatives JBP923 and JBP485 exhibit the antihepatitis activities after the gastrointestinal absorption in rats. Clin. Pharmacol. Ther. 294 (2000) 510-515
17. Lowin B., Hahne M., Mattmann C., and Tschopp J. Cytotoxic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370 (1994) 650-652
18. Morita M., Watanabe Y., and Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocytes adhesion. Hepatology 19 (1994) 426-431
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
20. Napoli J., Bishop G.A., McGuiness P.H., Painter D.M., and McCaughan G.W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24 (1996) 759-765
21. Sano K., Nagaki M., Sugiyama A., Hatakeyama H., Ohnishi H., Muto Y., and Moriwaki H. Effects of cytokines on the binding of leukocytes to cultured rat hepatocytes and on the expression of ICAM-1 by hepatocytes. Dig. Dis. Sci. 44 (1999) 796-805
22. Shechter O. Bound lectins that mimic insulin produce persistent insulin-like activities. Endocrinology 113 (1983) 1921-1926
23. Shier W.T. Concanavalin A as an inflammogen. In: Bittiger H., and Schnebli H.P. (Eds). Concanavalin A as a Tool (1976), John Wiley & Sons, New York 573-580
24. Taniguchi K., Kawano Y., Toshitani A., Karashima A., and Nomoto K. Anti-metastatic effect by in vivo administration of concanavalin a through augmentation of T derived activated killer activity: efficacy to B 16 melanoma expressed MHC antigen. Cell. Immunol. 120 (1989) 460-469
25. Tiegs G., Hentschel J., and Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90 (1992) 196-203
26. Trautwein C., Rakemann T., Malek N.P., et al. Concanavalin A-induced liver injury triggers hepatocyte proliferation. J. Clin. Invest. 101 (1997) 1960-1969
27. Volopes R., Vanden Oord J.J., and Desmet V.J. Hepatic expression of intercellular adhesion molecular-1 (ICAM-1) in viral hepatitis B. Hepatology 12 (1990) 148-154
28. Yagi A., Nagao, Okamura N., Ishizu T., Itoh H., and Shida T. Effect of cyclo (trans-4-l-hydroxyprolyl-l-serine) from hydrolysate of human placenta on baby hamster kidney -21/C-13 cells. Nat. Med. 52 (1998) 156-159
29. Ye R.G., and Lu Z.Y. Medicine. 6th ed. (2004), People's Medical Publishing House, Beijing
30. Yoshifumi W., Masahiko M., and Toshihiro A. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 24 (1996) 702-710